[Updated: 4/15/2021] Roche Covid-19 Therapy UpdateEarlier this week, Swiss pharma-giant Roche (OTCMKTS:RHHBY) introduced that Regeneron’s investigational antibody cocktail – casirivimab and imdevimab – decreased threat of symptomatic Covid-19 infections by 81%. As www.nasdaq.com
[Updated: 4/15/2021] Roche Covid-19 Therapy UpdateEarlier this week, Swiss pharma-giant Roche (OTCMKTS:RHHBY) introduced that Regeneron’s investigational antibody cocktail – casirivimab and imdevimab – decreased threat of symptomatic Covid-19 infections by 81%. As
www.nasdaq.com